|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 136.00 SEK | -2.02% |
|
-0.58% | -13.49% |
| 06-24 | Danske Bank cuts price target for Cellavision to 180 kronor (185), reiterates buy - BN | FW |
| 06-17 | Stockholm Stock Exchange trades near flat at the open, OMXS30 unchanged | FW |
Company Valuation: CellaVision AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,757 | 5,462 | 5,057 | 5,188 | 3,749 | 3,244 | - | - |
| Change | - | -29.58% | -7.42% | 2.59% | -27.72% | -13.49% | - | - |
| Enterprise Value (EV) 1 | 7,763 | 5,456 | 5,000 | 5,065 | 3,587 | 3,028 | 2,982 | 2,918 |
| Change | - | -29.71% | -8.37% | 1.31% | -29.18% | -15.58% | -1.51% | -2.15% |
| P/E | 61.9x | 46.2x | 38.8x | 36.9x | 24.5x | 23x | 18.8x | 16.3x |
| PBR | 14.3x | 8.51x | 7.06x | 6.36x | 4.22x | 3.3x | 2.98x | 2.68x |
| PEG | - | -8.36x | 3.8x | 4.58x | 2.78x | -2.98x | 0.8x | 1.1x |
| Capitalization / Revenue | 13.7x | 8.54x | 7.47x | 7.17x | 4.94x | 4.22x | 3.76x | 3.41x |
| EV / Revenue | 13.7x | 8.53x | 7.38x | 7x | 4.73x | 3.94x | 3.46x | 3.07x |
| EV / EBITDA | 39.6x | 27.5x | 24.2x | 23.2x | 14.9x | 13.5x | 11.2x | 9.68x |
| EV / EBIT | 47.7x | 34.5x | 29.9x | 28.5x | 17.8x | 16.9x | 13.5x | 11.5x |
| EV / FCF | 68x | 81.1x | 45.1x | 41.4x | 31.4x | 28.1x | 24.4x | 19.7x |
| FCF Yield | 1.47% | 1.23% | 2.22% | 2.42% | 3.19% | 3.55% | 4.09% | 5.06% |
| Dividend per Share 2 | 2 | 2 | 2.25 | 2.5 | 2.75 | 2.75 | 3.075 | 3.362 |
| Rate of return | 0.62% | 0.87% | 1.06% | 1.15% | 1.75% | 2.02% | 2.26% | 2.47% |
| EPS 2 | 5.25 | 4.96 | 5.46 | 5.9 | 6.42 | 5.924 | 7.239 | 8.349 |
| Distribution rate | 38.1% | 40.3% | 41.2% | 42.4% | 42.8% | 46.4% | 42.5% | 40.3% |
| Net sales 1 | 565.6 | 639.3 | 677.3 | 723.2 | 759 | 768.9 | 861.7 | 950.6 |
| EBITDA 1 | 196.2 | 198.4 | 206.8 | 218.7 | 241.4 | 224.2 | 266.4 | 301.5 |
| EBIT 1 | 162.7 | 158.3 | 167.1 | 177.7 | 202.1 | 179.2 | 220.5 | 254.4 |
| Net income 1 | 125.3 | 118.3 | 130.3 | 140.7 | 153.1 | 141.2 | 176.6 | 206.2 |
| Net Debt 1 | 6.368 | -5.558 | -56.94 | -122.6 | -162.6 | -215.7 | -261.4 | -325.7 |
| Reference price 2 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 | 136.00 | 136.00 | 136.00 |
| Nbr of stocks (in thousands) | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | - | - |
| Announcement Date | 2/4/22 A | 2/8/23 A | 2/7/24 A | 2/6/25 A | 2/5/26 A | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.96x | 3.94x | 13.5x | 2.02% | 334M | |
| 58.78x | 4.71x | 15.73x | 0.37% | 16.08B | |
| 33.76x | - | - | 2.4% | 1.44B | |
| 18.26x | 2.62x | 8.81x | 1.27% | 1.09B | |
| -8.62x | 1.2x | 5.24x | -.--% | 940M | |
| 55.23x | - | - | 0.81% | 561M | |
| 44.26x | - | - | - | 434M | |
| 18.55x | 2.61x | 11.17x | 1.84% | 380M | |
| -14.76x | - | - | - | 332M | |
| Average | 25.38x | 3.02x | 10.89x | 1.24% | 2.4B | |
| Weighted average by Cap. | 49.35x | 4.36x | 14.67x | 0.6% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CEVI Stock
- Valuation CellaVision AB
Select your edition
All financial news and data tailored to specific country editions
